However, although above results shall provide meaningful insights into better understanding of ccRCC, it’s not yet enough to classify FGF1 or other PI3K-AKT signaling proteins as new potential drug targets in ccRCC. The gene discussed is PIK3CG; the disease is nonpapillary renal cell carcinoma.